We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
The purpose of this study is to determine the safety and efficacy of the study drug deucravacitinib (also known as BMS-986165) compared to placebo.
This video will help participants considering to join the BMS IBD clinical study learn more about IBD and how the study medication BMS-986165 is thought to affect the gut.
1:28
divider
Click the links below to review complete eligibility criteria, study site locations, and contact information for these studies.
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information